Susan Galbraith, Executive Vice President in Oncology R and D at AstraZeneca, shared on LinkedIn:
“It was a great to attend the inaugural Astra Zeneca China Oncology Patient Advocacy Leaders Summit (PALS) which brought together nearly 100 patient advocates, clinicians, policymakers, academics and industry partners to advance a more patient – centered future for cancer care in China. We aligned around shared priorities, including earlier cancer detection, access to innovation, patient – centered clinical development and improved patient experience.
The patient stories shared were a powerful reminder of why the work we do matters and why we, at Astra Zeneca, feel so passionately about translating patient insights into tangible improvements in research, policy and care delivery.
Thank you to everyone who contributed to this event. Watch the video to see some of the action from the day and hear more from those who attended.
Proceed to the video attached to the post.”
Other articles featuring Susan Galbraith on OncoDaily.